Effects of non-fermented and fermented soybean milk intake on faecal microbiota and faecal metabolites in humans

International Journal of Food Sciences and Nutrition

Volumn 63, Issue 4, 2012, Pages 402-410

  Inoguchi, Shunsuke ^a   Ohashi, Yuji ^a   Narai Kanayama, Asako ^b   Aso, Keiichi ^b   Nakagaki, Takenori ^c   Fujisawa, Tomohiko ^b  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^c Nakagaki Consulting Engineer and Co LTD   (Japan)

Author keywords

Faecal metabolites; Faecal microbiota; Fermented soybean milk; Human; Soybean milk

Indexed keywords

PREBIOTIC AGENT; SULFIDE;

ADULT; ARTICLE; BACTERIUM; BIFIDOBACTERIUM; CHEMISTRY; CLINICAL TRIAL; CLOSTRIDIUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DRUG EFFECT; ESCHERICHIA COLI; FECES; FEMALE; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTESTINE; LACTOBACILLUS; MALE; METABOLISM; METAGENOME; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SOYBEAN; SOYBEAN MILK;

ADULT; BACTERIA; BIFIDOBACTERIUM; CLOSTRIDIUM; DIET; ESCHERICHIA COLI; FECES; FEMALE; FERMENTATION; HUMANS; INTESTINES; LACTOBACILLUS; MALE; METAGENOME; PREBIOTICS; REFERENCE VALUES; SOY MILK; SOYBEANS; SULFIDES; YOUNG ADULT;

BIFIDOBACTERIUM BIFIDUM; CLOSTRIDIA; CLOSTRIDIUM PERFRINGENS; ESCHERICHIA COLI; GLYCINE MAX;

EID: 84861022346     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2011.630992     Document Type: Article

References (44)

1. Adlercreutz H. 1998. Epidemiology of phytoestrogens Baillière's. Clin Endocrinol Metab 12:605-623.
2. Anderson JJB, Anthony M, Meessina M, Garner SC. 1999. Effects of phyto-oestrogens on tissues. Nutr Res Rev 12:75-116. (Pubitemid 29395041)
3. Benno Y, Endo K, Shiragami N, Sayama K, Mitsuoka T. 1987. Effects of raffinose intake on human fecal microflora. Bifidobacteria Microflora 6:59-63.
4. Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mitsuoka T. 1989. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 55:1100-1105. (Pubitemid 19120705)
5. Buddington RK, Williams CH, Chen SC, Witherly SA. 1996. Dietary supplementation of neosugar alters the fecal and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 63:709-716. (Pubitemid 26126589)
6. Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D. 2008. Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10:37-54. (Pubitemid 351756577)
7. Dunne C. 2001. Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis 7:136-145. (Pubitemid 32998502)
8. Fujisawa T, Shinohara K, Kishimoto Y, Terada A. 2006. Effect of miso soup containing Natto on the composition and metabolic activity of the human faecal flora. Microbiol Ecol Health Dis 16: 79-84. (Pubitemid 44844156)
9. Fukushima Y, Shou-tou L, Hara H, Terada A, Mitsuoka T. 1997. Effect of follow-up formula containing bifidobacteria (NAN BF) on fecal flora and fecal metabolites in healthy children. Biosci Microflora 16:65-72.
10. Fuller R. 1989. Probiotics in man and animals. J Appl Bacteriol 66: 365-378.
11. Gibons GR, Beatry EB, Wang X, Cummings JH. 1995. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterol 108:975-982.
12. Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401-1412.
13. Hara H, Li ST, Sasaki M, Maruyama T, Terada A, Ogata Y, et al. 1994. Effective dose of lactosucrose on fecal flora and fecal metabolites of humans. Bifidobacteria Microflora 13:51-63.
14. Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara I, Mitsuoka T. 1990. Effects of soybean oligosaccharides on human faecal flora. Microbiol Ecol Health Dis 3:293-303.
15. Isolauri E, Salminen S, Ouwehand AC. 2004. Probiotics. Best Pract Res Clin Gastroentel 18:299-313. (Pubitemid 38444132)
16. Karyadi D, Lukito W. 1996. Beneficial effects of tempeh in disease prevention and treatment. Nutr Rev 54:S94-S98. (Pubitemid 27179945)
17. Kries JL, Nout MJR, Rombouts FM, Nabuurs MJA, van der Meulen J. 2002. Inhibition of adhesion of enterotoxigenic Escherichia coli K88 by soya bean tempe. Lett Appl Microbiol 35:311-315. (Pubitemid 35205354)
18. Kurmann JA, Rasić JLJ. 1991. The health potential of products containing bifidobacteria. In: Robinson RK, editor. Therapeutic properties of fermented milks. London: Elsevier Applied Science. p 117-157.
19. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology:humnan gut microbes associated with obesty. Nature 444:1022-1023. (Pubitemid 46018512)
20. Ljungh A, Wadström T. 2006. Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol 7: 73-90. (Pubitemid 44130354)
21. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. 2001. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 73:430S-436S. (Pubitemid 32113267)
22. Masaoka Y, Watanabe H, Katoh O, Ito A, Doi K. 1998. Effects of miso and NaCl on the development of colonic aberrant cryptofoci induced by azoxymethane in F344 rats. Nutr Cancer 32:25-28. (Pubitemid 28519239)
23. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H. 1999. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted speciesspecific primers. Appl Environ Microbiol 65:4506-4512.
24. Matsumoto M, Imai T, Hironaka T, Kume H, Watanabe M, Benno Y. 2001. Effect of yogurt with Bifidobacterium lactis LKM512 in improving fecal microflora and defecation of healthy volunteers. J Intest Microbiol 14:97-102, (in Japanese with English summary).
25. Messina MJ, Persky V, Setchell KDR, Barnes S. 1994. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21:113-131. (Pubitemid 24127628)
26. Mitsuoka T. 2000. Significance of dietary modulation of intestinal flora and intestinal environment. Biosci Microflora 19:15-25.
27. Mitsuoka T, Sega T, Yamamoto S. 1965. Eine verbesserte Methodik der qualitativen und quantitativen Analyse der Darmflora von Menschen und Tieren. Zentralbl Bakteriol Hyg Orig 195: 455-469.
28. Mitsuoka T, Ohno K, Benno Y, Suzuki K, Namba K. 1976. Die Faekalflora bei Menschen. IV. Mitteilung: Vergleich des neu entwickelten Verfahrens mit dem bisherigen üblichen Verfahren zur Darmfloraanalyse. Zentralbl Bakteriol Hyg Abt Orig A234: 219-233.
29. Nagura T, Muraguchi H, Uchino K, Aritsuka T, Benno Y. 1999. Effects of ingestion of raffinose-rich soup on the fecal flora and daily defecation in humans. J Intest Microbiol 13:1-7, (in Japanese with English summary).
30. Narai-Kanayama A, Tokita N, Aso K. 2007. Dependence of fructooligosaccharide content on activity of fructooligosaccharide- metabolizing enzymes in yacon (Smallanthus sonchifolius) tuberous roots during storage. J Food Sci 72:S381-S387. (Pubitemid 47246955)
31. Nout MJR, Kiers JL. 2005. Tempe fermentation, innovation and functionality: update into the third millenium. J Appl Microbiol 98:789-805. (Pubitemid 40477254)
32. Nout MJR, Rombouts FM. 1990. Recent developments in tempe research. J Appl Bacteriol 69:609-633. (Pubitemid 20382054)
33. Ohara M, Lu H, Shiraki K, Ishimura Y, Uesaki T, Katoh O, Watanabe H. 2002. Prevention by long-term fermented miso of induction of colonic aberrant crypt foci by azoxymethane in F344 rats. Oncol Rep 9:69-73.
34. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. 2006. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511-521. (Pubitemid 46085405)
35. Rowland IR, Mallett AK, Wise A. 1985. The effect of diet on the mammalian gut flora and its metabolic activities. CRC Crit Rev Toxicol 16:31-103.
36. Sakai K, Tachiki T, Kumagai H, Tochikura T. 1987. Hydrolysis of b-D-galactosyl oligosaccharides in soymilk by b-D-galactosidase of Bifidobacterium breve 203. Agric Biol Chem 51:315-322.
37. Takiguchi R, Miyamoto M, Mochizuki E, Suzuki Y, Kageyama R, Iino H. 1998. Effects of fermented-milk administration on defecation and fecal microflora of healthy volunteers. J Intest Microbiol 11:117-122, (in Japanese with English summary).
38. Terada A, Hara H, Ikegame K, Sasaki M, Mitsuoka T. 1994. Recommended method for enumeration of lecithinase-positive clostridia in human feces. Bifidobacteria Microflora 13:27-30.
39. Terada A, Hara H, Sato D, Higashi T, Nakayama S, Tsuji K, et al. 1995. Effect of dietary chitosan on faecal microbiota and faecal metabolites of humans. Microbiol Ecol Health Dis 8:15-21.
40. Terada A, Yamamoto M, Yoshimura E. 1999. Effect of the fermented soybean product "Natto" on the composition and metabolic acitivity of the human fecal flora. Jpn J Food Microbiol 16:221-230.
41. Wada K, Mizutani J, Watabe J, Suzuki H, Shirayanagi S. 1991. Effects of soybean oligosaccharides intake on fecal microflora. Bifidus 5:51-54, (in Japanese with English summary).
42. Yaeshima T, Takahashi S, Matsumoto N, Ishibashi N, Hayasawa H, Iino H. 1997. Effect of yogurt containing Bifidobacterium longum BB536 on the intestinal environment, fecal characteristics and defecation frequency: a comparison with standard yogurt. Biosci Microflora 16:73-77.
43. Yang Y, He M, Hu G, Wei J, Pages P, Yang X, Bourdu-Naturel S. 2008. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated woman. World J Gastroenterol 28:6237-6243.
44. Yogo T, Ohashi Y, Terakado K, Harada Y, Nezu Y, Hara Y, et al. 2011. Influence of dried okara-tempeh on the composition and metabolites of fecal microbiota in dogs. Int J Appl Res Vet Med 9:181-188.